Evidence map›Paper›PMID 39000088›Full record

ArticleInternational journal of molecular sciences2024

Correlation between Neurotransmitters (Dopamine, Epinephrine, Norepinephrine, Serotonin), Prognostic Nutritional Index, Glasgow Prognostic Score, Systemic Inflammatory Response Markers, and TNM Staging in a Cohort of Colorectal Neuroendocrine Tumor Patients.

Radu Cristian Cîmpeanu, Mihail Virgil Boldeanu, Roxana-Viorela Ahrițculesei, Alina Elena Ciobanu, Anda-Mihaela Cristescu, Dragoș Forțofoiu, Isabela Siloși, Daniel-Nicolae Pirici, Sergiu-Marian Cazacu, Lidia Boldeanu and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Radu Cristian CîmpeanuDoctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Mihail Virgil BoldeanuDepartment of Immunology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID 0000-0003-2481-6138
Roxana-Viorela AhrițculeseiDoctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Alina Elena CiobanuDoctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Anda-Mihaela CristescuDoctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Dragoș ForțofoiuDoctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Isabela SiloșiDepartment of Immunology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Daniel-Nicolae PiriciDepartment of Histopathology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID 0000-0001-9192-7319
Sergiu-Marian CazacuDepartment of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID 0000-0001-9623-7683
Lidia BoldeanuDepartment of Microbiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID 0000-0002-4817-1365
Cristin Constantin VereDepartment of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroendocrine tumors are uncommon in the gastrointestinal system but can develop in the majority of the body's epithelial organs. Our goal was to examine the presence and clinical application of serum dopamine (DA), serotonin (ST), norepinephrine (NE), and epinephrine (EPI), in addition to determining the significance of the Prognostic Nutritional Index (PNI), Glasgow Prognostic Score (GPS), and systemic inflammatory response (SIR) markers as a prognostic factor for patients with colorectal neuroendocrine tumors (CR-NETs), in various tumor-node-metastasis (TNM) stages. We also wanted to identify the possible connection between them. This study included 25 consecutive patients who were diagnosed with CR-NETs and a control group consisting of 60 patients with newly diagnosed colorectal cancer (CRC). We used the Enzyme-Linked Immunosorbent Assay (ELISA) technique. This study revealed that CR-NET patients showed significantly higher serum levels of DA compared to CRC patients. We showed that serum DA was present in the early stages of CR-NETs, with increasing levels as we advanced through the TNM stages. Moreover, we found a close relationship between the levels of DA and the inflammation and nutritional status of the CR-NET patients in this study. CR-NET patients from the PNI < 47.00 subgroup had a higher level of DA than those from the PNI ≥ 47.00 subgroup. Pearson's correlation analysis revealed correlations between DA, PNI, and the neutrophil/lymphocyte ratio (NLR) and the platelet/lymphocyte ratio (PLR). Both hematological indices were negatively correlated with albumin (ALB). Our investigation's findings relating to the PNI, GPS, SIR, and DA indicate that these tools can be markers of nutritional and systemic inflammatory status, are simple to use, and are repeatable. Further research on this topic could provide valuable insights into which biomarkers to incorporate into clinical practice for the management of CR-NET patients.

Indexed as

Colorectal NeoplasmsDopamineEpinephrineNeoplasm StagingNeuroendocrine TumorsNorepinephrineSerotoninAdultAgedBiomarkers, TumorFemaleHumansInflammationMaleMiddle AgedNeurotransmitter AgentsBiomarkers, TumorDopamineEpinephrineNeurotransmitter AgentsNorepinephrineSerotonincolorectal neuroendocrine tumorsGlasgow Prognostic ScoreneurotransmittersPrognostic Nutritional Indexsystemic inflammatory response markers

Identifiers

PMID39000088
PMCPMC11241815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.